Home500124 • BOM
Dr Reddy's Laboratories Ltd
₹1,156.40
0.67%
+7.70 Today
May 9, 4:01:25 PM UTC+5:30 · INR · BOM · Disclaimer
In the news
Financials
Income Statement
020B40B60B80B
Revenue
Net Income
Revenue
Net income
(INR)Mar 2025Y/Y change
Revenue
85.06B20.09%
Operating expense
28.85B8.12%
Net income
15.94B21.95%
Net profit margin
18.741.57%
Earnings per share
19.8427.69%
EBITDA
22.97B32.22%
Effective tax rate
20.85%
0200B400B
Total Assets
Total Liabilities
Total assets
Total liabilities
(INR)Mar 2025Y/Y change
Cash and short-term investments
57.91B-28.92%
Total assets
492.99B27.22%
Total liabilities
155.82B45.67%
Total equity
337.17B
Shares outstanding
833.19M
Price to book
2.87
Return on assets
9.45%
Return on capital
12.17%
-2B02B4B6B
Net Change in Cash
Net change in cash
(INR)Mar 2025Y/Y change
Net income
15.94B21.95%
Cash from operations
22.00B90.94%
Cash from investing
-6.24B44.99%
Cash from financing
-14.43B-2,606.57%
Net change in cash
1.56B464.72%
Free cash flow
8.66B8.55%
StockIN listed securityIN headquartered
Previous close
₹1,148.70
Day range
₹1,130.05 - ₹1,166.25
Year range
₹1,025.90 - ₹1,420.20
Market cap
961.54B INR
Avg Volume
115.49K
P/E ratio
17.95
Dividend yield
0.69%
Primary exchange
NSE
About
Dr. Reddy's Laboratories Ltd. is an Indian multinational pharmaceutical company based in Hyderabad. The company was founded by Kallam Anji Reddy, who previously worked in the mentor institute Indian Drugs and Pharmaceuticals Limited. Dr. Reddy manufactures and markets a wide range of pharmaceuticals in India and overseas. The company produces over 190 medications, 60 active pharmaceutical ingredients for drug manufacture, diagnostic kits, critical care, and biotechnology. Dr. Reddy's began as a supplier to Indian drug manufacturers, but it soon started exporting to other less-regulated markets that had the advantage of not having to spend time and money on a manufacturing plant that would gain approval from a drug licensing body such as the U.S. Food and Drug Administration. By the early 1990s, the expanded scale and profitability from these unregulated markets enabled the company to begin focusing on getting approval from drug regulators for their formulations and bulk drug manufacturing plants – in more-developed economies. This allowed their movement into regulated markets such as the US and Europe. By 2007, Dr. Wikipedia
Founded
1984
Employees
27,048
Discover more
You may be interested in
This list is generated from recent searches, followed securities, and other activity. Learn more

All data and information is provided “as is” for personal informational purposes only, and is not intended to be financial advice nor is it for trading purposes or investment, tax, legal, accounting or other advice. Google is not an investment adviser nor is it a financial adviser and expresses no view, recommendation or opinion with respect to any of the companies included in this list or any securities issued by those companies. Please consult your broker or financial representative to verify pricing before executing any trades. Learn more
People also search for
Search
Clear search
Close search
Main menu
Google apps